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Abstract
Cellular receptor dynamics are often analyzed
using differential equations, making system dynamics
(SD) a candidate methodology. In some cases it may
be useful to model the phenomena at the biomolecular
level, especially when concentrations and reaction
probabilities are low and might lead to unexpected
behavior modes.
In such cases, agent-based
simulation (ABS) may be useful. We show the
application of both SD and ABS to simulate nonequilibrium ligand-receptor dynamics over a broad
range of concentrations, where the probability of
interaction varies from low to very low. Both
approaches offer much to the researcher and are
complementary. We did not find a clear demarcation
indicating when one paradigm or the other would be
strongly preferred, although SD is an obvious choice
when studying systems at a high level of aggregation
and abstraction, and ABS is well suited to studying
phenomena at the level of individual receptors and
molecules.

1. Introduction
This paper responds to the call by Scholl [1] for
cross-study and joint research into agent-based
simulation (ABS) and system dynamics (SD)
modeling. We contrast these two approaches in the
context of modeling cellular receptor dynamics.
We are aware of at least three fundamentally
different simulation paradigms that might be useful for
improving understanding of receptor dynamics: 1) SD
modeling (cf. [2]), which is differential equation

based; 2) traditional stochastic, discrete time, discrete
entity Monte Carlo simulation (cf. [3]); and 3) ABS
(cf. [4]). Each paradigm has strengths and limitations.
For example, SD is particularly well suited to studying
systems containing a complex web of feedback loops,
while discrete system simulation is preferred when the
system contains a high degree of uncertainty. A key
strength of ABS is its ability to incorporate spatial as
well as probabilistic aspects of the system.
This paper contrasts two of these paradigms, SD
and ABS, in terms of their ability to increase
understanding and inform research into the dynamics
of cellular receptors. Of particular interest is the way
in which these two paradigms may help to generate
complementary insights and increase the researcher’s
understanding of the dynamics of systems and
processes. This comparison considers the overall
approach, the underlying mathematics and analysis,
the ease with which results can be communicated to
others, research relevance, and educational potential.
As mentioned above, SD is based on ordinary
differential equations and their numerical solution
over time. The governing rate equations for the system
are developed, parameters are estimated, and the time
trajectories of the variables of interest are computed
and displayed. SD is a mature methodology that has
been applied in biomedical applications (cf. [5][6]).
Our background includes the application of SD to
biomedical systems, including pharmacokinetics
[7][8], epidemiological analysis, and non-equilibrium
receptor binding.
In ABS, the properties of the system emerge from
relatively simple rules governing the interactions of
independent agents located on a spatial grid [9]. This

paradigm originated in the field of biology, where
research into computer algorithms was being carried
out for the purpose of creating “artificial life.” In
recent years, software has become available to make it
easier to implement these algorithms and portray the
results graphically. Simple versions of the software,
such as StarLogo [10][11] are restricted to twodimensional models, although the concepts are easily
generalized to three dimensions.
For our comparison of SD and ABS, the
application area will be the study of non-equilibrium
binding of receptors on the surface of a cell in the
presence of different concentrations and types of
agonists and antagonists (cf. [12]). Most of the
research on receptors has been carried out from an
equilibrium perspective, but recently attention has
shifted to the behavior over time for the various
reactions. Both SD modeling and ABS facilitate such
analysis. We will focus specifically on the analysis of
positive and negative cooperative binding exhibited by
the divalent insulin receptor under various
experimental conditions. A recently published
differential equation based model for these dynamics
[13] provided the necessary details.
Motivating our interest in this area is the fact that
equilibrium-binding experiments are expensive and we
believe that simulation may contribute to the design
and interpretation of more efficient experiments. Most
researchers report only the final equilibrium
parameters, KD and Bmax, and not the forward and
reverse time constants for the reactions. To carry out
equilibrium-binding experiments, the biological
material must be isolated, expensive radioactive
ligands obtained, and pilot experiments conducted to
confirm the viability of the material over the time
horizon of the experiment and to determine the
concentration range and how long the equilibration
process takes. Unfortunately, experimental researchers
typically do not obtain transient data from their
experiments, perhaps due to logistical difficulties or
because they do not see any good reason to do so. Yet,
without these time constants, it is difficult to develop
credible dynamic computer models of these important
processes. We believe that the availability of
compelling and useful simulation models might
influence researchers to capture this additional data.
To provide a specific context for comparing SD
and ABS, we reviewed several biomedical papers that
presented relevant time-course data and/or models,
including receptor biosynthesis and degradation [14],
glucose transporter mechanisms [15], and insulin
receptor dynamics [13]. After creating initial
exploratory models, we selected the Wanant and Quon
paper on insulin receptor dynamics as the basis for
comparison. The primary advantages of this paper
were that the authors provided their parameter values

and differential equations, and also developed the
complexity of the model in a progressive fashion.

2. Background
Many cellular processes maintain some form of
relative equilibrium between multiple states of a fixed
amount of cellular component. Over time, the total
amount of the cellular component remains constant for
all practical purposes, but is reversibly converted
between two states, {A} and {B}, as shown in Figure
1.

Figure 1. Two states, {A} and {B}
For example, in the presence of soluble ligands
(small molecules such as drugs and hormones),
membrane-bound receptors exist in equilibrium
between the unbound state {A} and the bound state
{B} [16]. Normally inactive enzymes {A} are
activated by phosphorylation (to {B}), and inactivated
again by hydrolysis of the phosphate bond (back to
{A}) [17]. Drugs may be found in equilibrium
between water {A} and lipid {B} phases, depending
on their oil/water partition coefficients [18] [19].
Ligand-receptor (LR) binding is among the most
important of biological mechanisms. The binding
process is second order and depends on ligand
concentration, receptor concentration, and a forward
rate constant (k1_f; 1/mol2-time). Receptor
concentrations are usually normalized to 1 (or 100%),
and k1_f simplifies to 1/mol-time, dependent only on
ligand concentration. In the body, ligand
concentrations vary over time and from one location to
the next. In the laboratory, however, ligand
concentrations are often held constant during LR
binding experiments. Under these conditions, the
effective forward rate constant thus simplifies further,
carrying the familiar units of a first-order process:
k1_f_EFF = (1/mol-time) x ligand (mol) = 1/time

(1)

Given the assumption of constant ligand
concentration, binding can be described as shown
below, and binding decreases as unbound receptor R
is depleted.
(LR_associations/time) = R • k1_f_EFF

(2)

The LR complex also dissociates spontaneously, again
following first-order decay kinetics:
k1_r = 1/time

(3)

LR_dissociations/time = LR • k1_r

(4)

In contrast to binding, dissociations increase over
time as the LR concentration rises. Taken together, the
binding fraction LR/(R_total) approaches an
asymptote as the forward and reverse rates equalize.
The asymptote depends on the concentration of the
ligand, whereas the amount of time required to reach
the asymptote depends on the rate constants.
The Michaelis-Menten equation describes the
binding saturation as a function of ligand
concentration L:
Bound R = ((Total R) * L) / (KD + L)

(5)

KD (moles/l) is the concentration of L that leads to
half-maximal binding, as can be seen by (L)/(KD + L)
in the above equation. The concentration KD can also
be shown to equal k1_r/k1_f.
Binding experiments are typically conducted
with a series of incubation tubes containing fixed
receptor concentrations and with ligand concentrations
that remain fixed within each tube, but which increase
progressively from one tube to the next. Pilot studies
are used to determine how long the cultures must be
allowed to incubate before measuring the amount of
bound ligand in each tube.
Within each tube, binding occurs over time as an
inverted exponential process. When plotted for a series
of concentrations, receptor saturation (0-1) as a
function of ligand concentration resembles a
rectangular hyperbola. These data are usually plotted
on a log-concentration scale to produce a doseresponse curve that is often referred to as a sigmoid
dose-response curve. The midpoint of the curve (i.e.,
the concentration that half-saturates the receptor
population) is known as KD and is widely reported as a
measure of ligand-receptor affinity. Typical values
range from 1e-12 mol (picomolar) to 1e-6 mol
(micromolar), with smaller numbers indicating greater
affinity. Log curves are used because these widely
varying concentrations preclude the use of a linear
scale on the X-axis. KD can be readily determined and
compared for different ligands by visual inspection of
such graphs.
Another common representation of these same
data is known as the Scatchard plot. The ratio of
bound LR to the free ligand concentration is plotted on
the ordinate, against the bound LR on the abcissa. In
the case of a single species of receptor in the
incubation tube, the Scatchard plot yields a straight
line with slope = -1/KD (steeper slope indicates
higher affinity), and the x-intercept indicates the
maximum number of receptors bound (Bmax). Since the
actual number of receptors is generally unknown,

relative Bmax is generally reported as receptor density
per mg protein.
Biological preparations are often quite complex.
Incubation tubes may contain two or more types of
receptors that interact with the same ligand, each with
its own distinct rate constant. In this case, the
rectangular hyperbola and the log dose-response
curves are likely to appear to be distorted, depending
on the different rate constants present and the
stochastic noise of the system. Nonlinear Scatchard
plots are often seen, providing evidence of more
complex binding relationships. A binding site with
lower affinity (larger KD) will only be seen with
higher concentrations, and, since the KD is larger, the
slope (-1/KD) will be flatter. Taken together, these data
lead to a Scatchard plot that is concave upwards to the
left. With enough data points, it is sometimes possible
to resolve the curvilinear results into two straight lines,
thus establishing KD and Bmax for each of the two
receptor populations.
Other cases include multivalent receptors that
bind two (or more) ligand molecules per receptor.
Again, curvilinear Scatchard plots are obtained. In this
case, however, binding of the second ligand occurs as
a second-order delay and binding of the first ligand
may change the shape of the receptor complex, thus
altering the affinity of the second ligand molecule.
This interaction between subsequent ligands is known
as cooperative binding—negative if the second ligand
exhibits lower affinity and positive if the second
ligand exhibits higher affinity. Scatchard plots will
appear concave upwards or downwards, respectively.

3. Application of SD to receptor dynamics
3.1. Application of SD to simple 2SE processes
Because of the ubiquity of two-state equilibrium
(2SE) processes in biological systems, we believe that
a solid understanding of basic 2SE dynamics might
help researchers to improve the design and
interpretation of laboratory experiments involving
cellular processes. SD is easily and naturally applied
to the study of multi-state equilibrium processes. The
researcher/modeler specifies aggregate state variables
to represent the amount or concentration of both
unbound and bound receptors, with the flux from
unbound to bound and from bound to unbound
represented as unidirectional flows (rates of change).
Figure 2 illustrates the generic structure of a simple
2SE model. This model assumes that material is
conserved: {A}t + {B}t = 1 (or 100%) for all t.
We implemented the simple 2SE model using one
of the popular SD packages, STELLA [20], and
created a user interface to facilitate experimentation

with the model. Although we were already quite
familiar with 2SE processes, the activity

Figure 2. Generic 2SE model
of constructing and experimenting with these
admittedly very simple SD models was invaluable—
forcing us to clarify our understanding of the
underlying phenomena, which in turn enhanced our
ability to infer what “should” happen under different
circumstances.

It is relatively easy to add additional states
and additional reaction processes to an SD model
in order to model such phenomena as the
interaction of agonists and antagonists, the
opening and closing of ligand-gated ion channels,
initial binding events that trigger a sequence of
reactions (as in the case of second-messenger
cascades), or divalent receptors that exhibit
positive and negative cooperative binding.

After the binding of the first ligand, the divalent
receptor model assumes that a second ligand may bind
to the same receptor. The first-order rate constant of
association for the second ligand is k2_f. Because only
one binding site on this receptor is available, k2_f is
not doubled. The effective rate of this constant,
k2_f_EFF, is the product of ligand concentration and
the concentration of available singly bound receptors.
The dissociation constant for the doubly bound ligand
is k2_r.
Parameter values for the simulation runs
corresponded to the values used by Wanant and Quon.
Receptor concentration was kept constant at 1 x 10-10
M. The range of insulin concentration was 1 x 10-14 to
1 x 10-6 M. Insulin concentrations were varied in a
fashion similar to the way experiments are performed
in the laboratory. The data from these simulation runs
were used to generate Scatchard plots in order to
verify that the SD model generates data comparable to
the differential equation models used by Wanant and
Quon.
The default values for forward and reverse rate
constants were also those chosen by Wanant and
Quon. The range of values was consistent with
published values, 3 x 105 to 4 x 106 M-1 s-1 for k1_f
and 1 x 10-4 to 1 x 10-3 s-1 for k1_r. Based on the
results of Pang and Shafer (1984) and DeMeyts, et al
(1976), as reported by Wanant and Quon [13], k2_r =
100*k1_r.
We first implemented the divalent insulin receptor
model in STELLA. Figure 3 shows the STELLA
version. Rate constants are defined as described above.
By adjusting the rate constants k1_f, k1_r, k2_f, and
k2_r, one can simulate both positive or negative
cooperative binding.

We implemented the divalent insulin receptor
model described by Wanant and Quon [13] using
STELLA. This is a 3SE system, with three state
variables used to represent the three possible receptor
states: unbound, singly bound with one insulin
molecule, and doubly bound with two insulin
molecules. Receptor-ligand binding kinetics of the
first insulin molecule are represented by a bimolecular
reaction where the first-order rate constant of
association is k1_f and dissociation is k1_r. In order to
represent the availability of the two binding sites on
the divalent receptor, the forward rate constant, k1_f,
is multiplied by two. Because the forward rate
constant is dependent on ligand concentration, there is
an effective rate of association, k1_f_EFF, which is
the product of ligand and receptor concentrations.

insulin

k1 f

3.2. Application of SD to insulin receptor
dynamics

k1 f EFF
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FIGURE 3. Divalent insulin receptor model in
STELLA

Figure 4 illustrates the binding of radioactive
ligand to a monovalent receptor (simulated by setting
k2_f to zero). Each trace on the graph represents a
different ligand concentration in the simulated
incubation tube. This is done using automated
sensitivity analysis. With increasing ligand
concentration, the receptor is progressively saturated.
In addition, the equilibration time decreases with
increasing dose because of the increase in k1_f_EFF.

The x-intercept indicates the concentration of receptor,
in this case
1e-10
moles/liter.
The slope

Figure 6. Scatchard plot from SD model
indicates −1/KD, which identifies the half-maximal
binding concentration.

3.3. Summary

Figure 4. Fraction bound over time with different
ligand concentrations
Figure 5 shows a log dose-response curve
produced by the STELLA model. The smooth sigmoid
curve suggests the presence of a single receptor
population. Producing this type of graph in STELLA
required the use of comparative x-y graphs and special
logic to suppress most of the trace so that only the
endpoint of each comparative run shows.

The results from the SD model match the data
presented in the literature, and SD modeling appears to
be an excellent fit for the analysis of multi-state
equilibrium processes. We also determined that the
software is able to create the types of plots and charts
used by biomedical researchers. By building SD
models and understanding their structural properties,
and through experimentation with widely varying
parameter values, the researcher would be able to
significantly enhance their intuition regarding the
underlying biological processes, and thereby enhance
their ability to design and interpret laboratory
experiments and experimental data.

4. Application of ABS to receptor dynamics

Figure 5. Log dose-response curve
Figure 6 provides a Scatchard plot. The fact that it is
linear is also indicative of a single receptor population.

For our comparison, we selected StarLogo, an
introductory two-dimensional ABS package that may
be downloaded from MIT [11]. Originally developed
for educational use, it has more than enough capability
to model multi-state receptor dynamics.
One approach for doing so is to treat the
background grid of spatial locations as a portion of the
cell surface. In StarLogo, each grid location is called a
patch. A small percentage of these patches (identified
by their x-y coordinates on the grid) are specified to be
receptor sites. The initial state of these receptors is
either bound (with a molecule) or unbound. The
molecules are modeled as agents. In ABS models, the
motion of agents typically has a random component.
In the receptor example, the motion is purely random
(i.e., Brownian motion). As time proceeds in the

simulation, the molecules (agents) come into contact
with the receptors. Upon contact, the molecules
sometimes bind to the receptor, with a binding
probability near zero. Given sufficient time, however,
bindings do occur. Once bound, receptors unbind with
a particular probability, freeing up the previously
bound molecule.
If two different types of ligand molecules are
present, such as agonists and antagonists, the receptor
could be in one of three states (unbound, bound to
agonist, and bound to antagonist), so it would be a
type of 3SE model, but different from the 3SE model
discussed in Section 3.2 where there is only one type
of ligand molecule, but the receptor is divalent.
In ABS, The binding logic is implemented as a
small computer program. Other programs establish
initial conditions and carry out other administrative
functions. As model complexity increases, more
programs are written. The divalent receptor, for
example, would be implemented with the addition of a
doubly bound state for the receptor, plus additional
functions to represent the transition to and from the
doubly bound state. Similar additions could account

for channel opening and closing, and other complex
processes.
In StarLogo, the user interacts with the model
using various controls such as buttons and sliders. For
example, a <setup> button might be used to establish
the initial conditions, and a <go> button might be used
to cause the model to run. Various “sliders” are used
to set the values of parameters, such as the number of
receptors, constants used to determine the probability
of binding and unbinding, etc. When a model is run,
icons representing the different types of agents
(molecules and/or receptors) appear on the screen,
moving around and/or changing state (based on their
logic). The state of an agent is represented by its color
and/or the shape of its icon. For example, when a
molecule contacts a receptor, it may bind to it, which
could be represented by the receptor changing color or
shape. Over time, the receptors might eventually
change back to their original color or shape, signifying
that the molecule has unbound from the receptor.
Figure 7 shows the Starlogo user interface from our
model.

Figure 7. StarLogo model interface
The number of agents over time that meet various
criteria may be plotted, and, with a few lines of
programming, data regarding the number of bound and
unbound molecules over time may be saved to a file
for subsequent analysis using Excel or a statistical
analysis package. It is also relatively easy to program
StarLogo to conduct a set of experiments wherein the
model is run repeatedly, with parameters being varied
in a systematic fashion. An experiment might consist

of a single model run or several runs with the same
parameter values but with different random numbers.

4.1. Application of ABS to simple 2SE processes
We first programmed the simple 2SE model with
the receptors represented as patches and the molecules
represented as agents. We graphed the number of
bound and unbound receptors over time. We were
mesmerized by the visual effects of the “molecules”
dancing about, binding to the receptors, the receptors

changing color and then reverting back. We adjusted
the probabilities dynamically and “experienced” the
equilibrium point shift (through the changing colors on
the screen), either quickly or slowly, and either to a
large degree or to a lesser degree, depending on how
the parameters were changed.
We imagined what it would be like to connect the
model to a planetarium-like projector that would fill
an entire hemisphere with tens of thousands of
receptors and millions of molecules; the observer
would seem to be inside a cell looking outwards
toward the cell surface watching the biochemistry at
work on the surface. We viewed the plots with
different parameter values and were intrigued by the
random effects superimposed on the essentially monoexponential graphs.

4.2. Application of ABS to Insulin Receptor
Dynamics
Initially we thought we would continue to model
the receptors as coordinates on the x-y grid (patches in
StarLogo), but we soon realized that it is
computationally more efficient to model the receptors
as agents, even though we did not anticipate having
them move. Our initial divalent insulin model used
agents to model both ligand molecules and receptors.
Although watching the molecules move around
and sometimes bind to a receptor “felt right,” as we
began to run experiments, we quickly realized that in
order for the model to even remotely resemble
biological reality, we would need to have at least 103
receptors. With realistic binding probabilities, the
number of ligand (insulin) molecules would need to be
several orders of magnitude higher, which is not
possible in StarLogo. We were stymied until one of
the authors said, “I’ve been pondering our dilemma,
and I don’t think we really need the molecules!” It
sounded like heresy! But they were right. All we
needed to model was the probability of a receptor
binding in a given time period. The model ran
dramatically faster.
In order to reproduce the binding experiments, we
wrote logic to execute a sequence of runs with varying
ligand concentrations. We provided sliders to set the
lower and upper ligand concentration. The model
determined how many runs were needed, at four
values per decade, on a log scale. We began running
experiments and quickly realized that at lower
concentrations the model needed to run much longer
to reach equilibrium and that there was considerable
variance in the ending number of bound ligand
molecules from one run to the next. The total number
of bound ligand molecules is the number of singly
bound receptors plus two times the number of doubly
bound receptors. These are the numbers typically

obtained from the binding studies using radioactive
ligands. Making the necessary runs took many hours
in StarLogo. We tried using a time interval deltaT
greater than 1 second in order to shorten the run time.
In these runs, the probability was multiplied by deltaT,
and time was advanced each iteration by deltaT
instead of 1. With a deltaT of 10, the runs were 10
times faster, but due to the variance in the ending
number of bound receptors, we were not confident that
we had accurately determined the asymptote. At the
lowest concentration, we knew that the theoretical
value was 50, but we obtained values from 33 to 65.
We instrumented the model to make multiple runs
with the same parameter values. We spent countless
hours making multiple runs in order to assure
ourselves that the results were due to inherent
randomness and not model errors.
Table 1 provides sample lab notes from these
runs. Note that the reaction rate parameters are
integers. This is because StarLogo provides integer
valued random numbers rather than Uniform[0,1]
random numbers. We began by expressing the reaction
probabilities as numbers between 0 and 1000, but soon
realized we needed to increase the upper limit. In Runs
A, B, and C we used 0 to 100000, and by Runs D and
E we had converted the model to express them as
numbers between 0 and 1000000. The decisive run
(not shown in Table 1) was for 40000 seconds (five
times longer than what we had thought was necessary)
using a deltaT of 1 second. The data from this run
showed an approximate asymptote of 50 with
considerable variance, increasing our confidence in the
model.
A separate issue was that at higher concentrations
equilibrium came quickly. We reduced the print
interval and shortened the run times, since the longer
runs necessary at lower concentrations were
superfluous. Overall, considerable “babysitting” was
required during the experimental runs, to adjust the
run length and because StarLogo simply stopped
Table 1. Lab notes regarding multiple model runs
at low concentrations
Concentration
1.00E-11
1.78E-11
3.16E-11
5.62E-11
1.00E-10

Run A
33
49
125
178
287

Final # Bound
Run
B
Run C Run D
48
65
37
71
87
87
133
127
n/a
213
237
n/a
316
321
n/a

Run E
39
91
131
238
305

4000
2
40
1

8000
10
200
5

8000
20
400
10

Parameters

Run Length
K1f
K1r
K2f

8000
2
40
1

8000
20
400
10

K2r
DeltaT
Prob=1

8000
1
105

40000 8000
5
1
105
105

80000
1
106

80000
1
106

running from time to time for no reason we could
determine. Figure 7 shows the final StarLogo model
and Table 2 shows a selection of the model logic.
Table 2. StarLogo code fragments from the
divalent insulin receptor model
setsim_num 0
An illustrative
setligconc (10 ^ ligconc_lower)
segment of the
calc-keffs
control logic
setnumber_sims 4 * (ligconc_upper for running
ligconc_lower) + 1
repeat number_sims
experiments,
[
potentially
setsim_num sim_num + 1
multiple times
setrun_num 0
for a given
repeat runspersetting
[
ligand
setrun_num run_num + 1
concentration
run-sim
]
setligconc ligconc * (10 ^ .25)
calc-keffs
to calc-keffs
setK1f_eff1000000 1000000 * 2 * ligconc
* K1f * (10 ^ K1f_exp) * deltaT
setK2f_eff1000000 1000000 * ligconc *
K2f * (10 ^ K2f_exp) * deltaT
setK1r1000000 1000000 * K1r * (10 ^
K1r_exp) * deltaT
setK2r1000000 1000000 * 2 * K2r * (10 ^
K2r_exp) * deltaT
To check-bind
if (state = unbound)
[
if (random 1000000) < K1f_eff1000000
[
ifelse ((random 100) < 50)
[setshape shape-R_XR]
[setshape shape-XR_R]
setstate bound
setstate_num -1

Figure 9 shows receptor saturation vs. ligand
concentration, yielding the expected rectangular
hyperbola.

Figure 8. Ligand-receptor binding vs. time

Logic to
calculate the
reaction
constants for a
given ligand
concentration
Figure 9. LR binding vs. ligand concentration
A fragment of
an agent
procedure that
determines if
binding will
occur, and if so,
what happens

Figures 8-11 were created using Excel from the
data collected during the many experiments that we
ran. Data from the StarLogo runs was written to the
output window in a tab-delimited format to allow
quick and easy transfer to Excel.
Figure 8 shows simulations of insulin binding to
the high-affinity site of the divalent insulin receptor.
Insulin concentrations were held constant at 1e-11,
1.7e-11, 3.2e-11, 5.6e-11, and 1e-10 nM. These
concentrations saturate about 50% of the receptor
sites. Three simulations were conducted at each
concentration, showing the stochastic variability
observed, even with just 1000 receptors in the model.
The observed variability decreases considerably with
larger numbers of receptors, but at the cost of a
significant increase in simulation times.

Figure 10 illustrates the sigmoidal dose-response
curve. With simple monovalent receptors, a single
sigmoidal curve would be expected in the lower left
graph. In this case, however, the lower left portion
of the curve shows the ligand approaching saturation
of the first (high-affinity) site (density = 1 ligand per
receptor). As the concentration rises further, the
second (low-affinity) site begins to bind, ultimately
saturating the receptor with two ligand molecules per
receptor.

Figure 10. Log dose-response curve
Figure 11 is a Scatchard plot of the data shown in
Figure 10. The linear portion of the curve to the left is

due to the high-affinity site; the slope = -1/KD
(affinity), and the x-intercept indicates Bmax, or the
density of receptors. In this simulation, Bmax is 0.1
nM/liter, as described in Wanant and Quon [13]. The
Scatchard plot is concave upwards to the left,
indicating the presence of a second, low-affinity
binding site in the incubation tube. Further laboratory
experiments would be required to determine if the
concavity is due to a single divalent receptor
population or two separate receptor populations with
different binding characteristics.

Figure 11. Scatchard plot, divalent insulin receptor

4.3. Summary
Visualization and the ability to vary aspects of the
simulation dynamically are excellent in ABS. It is easy
to communicate simulation results to others by having
them observe the simulation. By watching the motion
and color changes of agents and observing graphs over
time regarding the number of various types of agents
present, both students and researchers can gain
insights into the functioning of cellular receptors. In
addition to seeing the receptors bind and unbind,
observers can see the variability in the runs with low
ligand concentration, an aspect of realism that is not
apparent with SD models.
The rules governing behavior are embedded in
computer programs, which might tend to make the
models less accessible. However, the logic is in fact
rather simple and quite easy to read and comprehend.
With adequate documentation of the program, an
individual with little or no programming experience
can understand the functions of the various
subprograms. Thus, ABS is a good candidate for
collaborative work between individuals with
specialized knowledge about a given phenomenon and
individuals with programming skills.
We also found some limitations when using
StarLogo for this type of research. Due to the slow
execution speed, we often had to “baby-sit” the
simulation runs, customizing the run parameters for
each run in order to gain efficiency. When we tried to
make long unattended runs, we found that for no

apparent reason StarLogo often stopped running after
an indeterminate number of hours.
Nevertheless, we found that ABS can help
provide insights into receptor binding that are difficult,
if not impossible, to derive from SD models alone.

5. Overall Comparison of SD and ABS for
Studying Receptor Dynamics
System dynamics models portray the structure of
the interrelationships between variables very
effectively and allow the user to easily experiment
with different parameter values and compare the
resulting graphs of behavior over time. SD models
may be considered more conceptually descriptive than
ABS models, and they force the modeler to consider
carefully the appropriate level of aggregation.
STELLA is easy to use and highly “approachable.”
However, sensitivity testing with non-trivial STELLA
models is very time consuming (although orders of
magnitude faster than with StarLogo).
The agent-based simulation paradigm forces the
modeler to consider carefully the definition of agents
and to specify their behavioral rules in the simplest
possible fashion. ABS models are spatial and are able
to easily portray interactions at the cellular/molecular
level. This allows the model to reflect, among other
things, the random way in which molecules bind and
unbind with receptors. Thus, ABS is ideally suited for
studying problems when the probability of interaction
is low and the stochastic aspects of the process are
important.
We found the process of developing and testing
models using two very different paradigms to be
incredibly useful. We believe that both paradigms
could be productively used to help educate biomedical
researchers and assist with laboratory research.
Conducting dynamic experiments on the computer and
observing simulations unfolding on the screen greatly
enhances awareness of the interesting underlying
dynamics. We believe that this enhanced awareness
would lead to the design of better laboratory
experiments in this important area of research. SD
might be a more appropriate research tool, but ABS
models may be better suited for educational purposes.
Although a scientist doing advanced research on
receptor dynamics might prefer SD models, a student
or researcher still learning about receptor dynamics
might benefit by first creating ABS models.
Researchers who use either of these paradigms are
more likely to design laboratory experiments that fully
characterize the time dynamics of the processes being
studied.
We conclude with a comparison of SD and ABS
in terms of overall approach, mathematics, ease of

communications, research relevance, and educational
potential (Table 3).
Table 3. Comparison of SD and ABS
System Dynamics (STELLA)
Agent Based Simulation (StarLogo)
Physical emulation of “agents” whose rules for
Overall approach Abstract, via state variables and equations that are
Mathematics
Ease of
communications
Biomedical
research
relevance

Educational
potential

solved to simulate behavior over time
Calculus; numerical integration of difference
equations
Very good for showing model structure and numerical
results
Appropriate for modeling the aggregate behavior
resulting from interactions between multiple types of
material. However, the reliance on variables that lump
together all of the material of a particular type makes
it difficult to address unique behavior and dynamics at
the entity level and to show how the aggregate
behavior might emerge. Its use in biomedical research
is likely to increase as the software becomes
increasingly user friendly and is further adapted for
biomedical applications
Particularly useful for increasing conceptual
understanding, especially regarding the very powerful
and general methodology of compartmental analysis
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